After years of using its digital health feedback system in clinical trials and studies, Proteus Digital Health, and partner Otsuka Pharmaceuticals, are poised to launch the first mass market drug to incorporate Proteus's ingestible sensor. The companies have submitted a sensor-embedded version of the antidepressant Abilify for FDA approval.
“Today, patients suffering from severe mental illnesses...
Sanofi's IBG Star connected glucometer.
Google Life Science's recently-announced partnership with Dexcom (not to mention its contact lens project with Novartis) have already made it clear that diabetes is a focus for the company. Now the company is making that focus official in a new partnership with Sanofi and the Joslin Diabetes Center.
"Today, we’re announcing a new partnership with Sanofi...
Johnson and Johnson Innovation (JJI) is teaming up with hardware manufacturing company PCH to create Hardware for Health, an accelerator of sorts for companies with a consumer health oriented hardware prototype.
"If you look at what’s happening in hardware, there’s really a renaissance going on," Stacy Feld, Senior Director of Consumer Scientific Innovation at JJI, told MobiHealthNews. "There...
Sendinaden Pattern Breathe Mask
Pharma company Bayer HealthCare has announced the next five startups that will take part in the company's Grants4Apps accelerator program in Germany.
Startups in Bayer's f0ur-month accelerator receive around $58,031 (50,000 euros) and coaching from Bayer executives as well as other industry experts.
The accelerator's first class was announced in August last year...
Adherium Limited, a New Zealand company working on a smart inhaler, has raised $25.6 million ($35 million AU) in an initial public offering on the Australian Securities Exchange, including a $3 million investment from its partner pharma company AstraZeneca, which just last month announced a longterm commercialization agreement with the company.
Adherium makes a line of medical devices that...
Roche Pharma Research and Early Development, a division of Roche Pharmaceuticals, has developed a new mobile app to measure Parkinson's disease symptoms. The app was developed in partnership with Max Little, a British mathametician at the head of the Parkinson's Voice Initiative, and it will actually be used in a drug development trial with Prothena Biosciences.
“The app is being used in a Phase...
Sixty-six percent of all pharma app downloads in the United States, the United Kingdom, and Germany, were downloads of the top 10 apps according to an infographic recently released by German app company SmartPatient (not to be confused with Roni Zeiger-founded online patient community SmartPatients). SmartPatient's iOS and Android app is called MyTherapy.
The Munich-based company analyzed 359...
A Junto Health working group meets at the last team summit.
There are a lot of digital health accelerators designed to help startups catch the eye of big pilot partners, but what about the other way around? Last December NYC-based tech accelerator Blueprint Health spun off the Blueprint Health Collective, now renamed Junto Health, to help stakeholders like payers, pharma companies, and...
AstraZeneca has partnered with New Zealand-based Adherium Limited, which offers a mobile-enabled inhaler, to incorporate digital health offerings into AstraZeneca’s patient support programs for people with COPD and asthma.
Adherium's Smartinhaler sends data on when medication was taken to mobile devices and desktop computers via Bluetooth. The platform is designed to help patients, caregivers,...
Madison, Wisconsin-based Propeller Health has secured two new FDA clearances for new sensors that are designed to work with two particular inhalers on the market: the Diskus inhaler from GlaxoSmithKline and the Respimat inhaler from Boehringer Ingelheim. Unlike previous FDA clearances for Propeller, the new clearances actually allow Propeller to market its new devices as improving — not just...
